OLEXEN, CINTHIA MARIEL; ROSSO, DIEGO

Rapid detection of pathological CD1a+CD207+ myeloid circulating cells in blood and their implication in Langerhans cell histiocytosis.

Reunión de Sociedades de Biociencias 2020

Año: 2020;

ROSSO, DIEGO; OLEXEN, CINTHIA MARIEL

CD207+/CD1a+ circulating cells show higher levels of TYRO3, MERTK, and PROS1 in patients with active Langerhans cell Histiocytosis.

35th Annual Meeting of the Histiocyte Society

Año: 2019;

ROSSO D; TESSONE L; ESTECHO I; ERRASTI A

CD 207/CD1A circulating cells are present in patients with active Langerhans cell Histiocytosis.

Annual Meeting of the Histiocyte Society.

Año: 2016;

ROSSO D; TESSONE L; CARRERAS SILVA A; ERRASTI A

Increased TYRO3 and Protein S expression in circulating monocytes and T cells seem to correlate with activity of LCH.

31st Meeting of the Histiocyte Society

Año: 2015;

RAMOS A; D`ALOI K; ROSSO D; ELENA G

HEMOGLOBINURIA PAROXISTICA NOCTURNA: UNA ENFERMEDAD DE EXPRESION VARIABLE.

XXII Congreso de Hematología, II Simposio Conjunto de la Asociacion Europea de Hematologia y la SAH.

Año: 2015;

ROSSO D; CABRAL CASTELLA C; CESY PEDRINI; ANGELICA BLANCO; ERICA ROJAS BILBAO

MUTACIONES BRAF y KRAS FUERON NEGATIVAS EN UN SARCOMA DE LANGERHANS REFRACTARIO DE UN CHICO.

II Simposio Conjunto de la Asociacion Europea de Hematologia y la SAH

Lugar: Mar del Plata; Año: 2015;

GONZALEZ A; ROSSO D; ELENA G

LNH DIAGNOSTICADO COMO PRECURSOR B POR CITOMETRIA DE FLUJO Y ANATOMIA PATOLOGICA PERO B MADURO POR CITOGENETICA Y FISH.

XXII Congreso de Hematología, II Simposio Conjunto de la Asociacion Europea de Hematologia y la SAH

Año: 2015;

CARRERA SILVA EA; ROSSO D; TESSONE L; ERRASTI A

Rol de los receptores tirosina quinasa TAM en la fisiopatología de la Histiocitosis de Células de Langerhans pediátrica.

AESAIC-SAFIS

Lugar: Mar del Plata; Año: 2015;

BRAIER JL; ROSSO D; AMARAL D; LATELLA A

INTERMEDIATE DOSE OF CLADRIBINE AND CYTARABINE IS EFFECTIVE AND WELL TOLERATED IN RESSISTANT RISK ORGAN LCH PATIENTS

30th Histiocyte Annual Meeting

Lugar: Toronto; Año: 2014;

ROSSO D

Malignant Histiocytosis

29th Histiocyte Annual Meeting

Año: 2013;

ROSSO D; BALESTRINI STELLA; SANTIDRIAN VALERIA; RECONDO EZEQUIEL

INDOMETHACIN WAS EFFECTIVE IN TWO PATIENTS WITH LCH IN ?SPECIAL SITES?

29th Histiocyte Annual Meeting

Año: 2013;

ROSSO D; BALESTRINI STELLA; SERRANO CANDELARIA; DIOMENDI LUCIA; RECONDO EZEQUIEL

Hemophagocytic syndrome during induction therapy for ambiguous lineage (B/My)acute leukemia

29th Histiocyte Annual Meeting

Año: 2013;

BRAIER JL; POLLONO D; REY G; ROSSO D

INDOMETHACIN AS A SINGLE AGENT OF TREATMENT OF PATIENTS WITH BONE LANGERHANS CELL HISTIOCYTOSIS AT DIAGNOSIS OR AFTER REACTIVATION

Histiocyte Society 28th Annual Meeting

Lugar: Londres; Año: 2012;

ROWENSTEIN E; ROSSO D; FRAQUELI L; RICHARD L; PIERRO E

EXTRANODAL ROSAI DORFMAN DISEASE. FOUR PATIENTS: DIFFERENT TREATMENTS, DIFFERENT OUTCOMES

Histiocyte Society 27th Annual Meeting

Año: 2011;

ROSSO D; ALDERETE D; SOLERNOU V; ROJAS BILBAO E

HISTIOCYTIC SARCOMA. TWO CASES: SAME DIAGNOSIS, DIFFERENT RESPONSE TO THERAPY

Histiocyte Society 27th Annual Meeting

Lugar: Viena; Año: 2011;

RUVINSKY S; PAULIN P; BORCHICHI S; ROSSO D; ORDUNA

HEMOPHAGOCYTIC SYNDROME ASSOCIATED WITH VISCERAL LEISHMANIASIS IN PEDIATRIC PATIENTS IN ARGENTINA: A MULTICENTRE STUDY

Histiocyte Society 26th Annual Meeting

Lugar: Boston; Año: 2010;

BRAIER JL; ROSSO D; CHANTADA G; LATELLA A; BALANCINI B; BERNALDEZ P; VAIANI E; GOLDBERG J.

REACTIVATION AND SEQUELAE IN MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS AT A SINGLE INSTITUTION

Histiocyte Society 26th Annual Meeting

Lugar: Boston; Año: 2010;